GB0218590D0 - Therapeutic use of aryl amino acid derivatives - Google Patents

Therapeutic use of aryl amino acid derivatives

Info

Publication number
GB0218590D0
GB0218590D0 GBGB0218590.8A GB0218590A GB0218590D0 GB 0218590 D0 GB0218590 D0 GB 0218590D0 GB 0218590 A GB0218590 A GB 0218590A GB 0218590 D0 GB0218590 D0 GB 0218590D0
Authority
GB
United Kingdom
Prior art keywords
amino acid
acid derivatives
therapeutic use
aryl amino
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0218590.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB0218590.8A priority Critical patent/GB0218590D0/en
Publication of GB0218590D0 publication Critical patent/GB0218590D0/en
Priority to CA002495108A priority patent/CA2495108A1/en
Priority to BR0313284-6A priority patent/BR0313284A/en
Priority to EP03784335A priority patent/EP1528919A2/en
Priority to MXPA05001534A priority patent/MXPA05001534A/en
Priority to PCT/IB2003/003193 priority patent/WO2004014357A2/en
Priority to AU2003247056A priority patent/AU2003247056A1/en
Priority to JP2004527144A priority patent/JP2006507238A/en
Priority to US10/636,406 priority patent/US7053122B2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
GBGB0218590.8A 2002-08-09 2002-08-09 Therapeutic use of aryl amino acid derivatives Ceased GB0218590D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0218590.8A GB0218590D0 (en) 2002-08-09 2002-08-09 Therapeutic use of aryl amino acid derivatives
CA002495108A CA2495108A1 (en) 2002-08-09 2003-07-29 Therapeutic use of aryl amino acid derivatives
BR0313284-6A BR0313284A (en) 2002-08-09 2003-07-29 Therapeutic use of aryl amino acid derivatives
EP03784335A EP1528919A2 (en) 2002-08-09 2003-07-29 Therapeutic use of aryl amino acid derivatives
MXPA05001534A MXPA05001534A (en) 2002-08-09 2003-07-29 Therapeutic use of aryl amino acid derivatives.
PCT/IB2003/003193 WO2004014357A2 (en) 2002-08-09 2003-07-29 Therapeutic use of aryl amino acid derivatives
AU2003247056A AU2003247056A1 (en) 2002-08-09 2003-07-29 Therapeutic use of aryl amino acid derivatives
JP2004527144A JP2006507238A (en) 2002-08-09 2003-07-29 Therapeutic use of aryl amino acid derivatives
US10/636,406 US7053122B2 (en) 2002-08-09 2003-08-07 Therapeutic use of aryl amino acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0218590.8A GB0218590D0 (en) 2002-08-09 2002-08-09 Therapeutic use of aryl amino acid derivatives

Publications (1)

Publication Number Publication Date
GB0218590D0 true GB0218590D0 (en) 2002-09-18

Family

ID=9942061

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0218590.8A Ceased GB0218590D0 (en) 2002-08-09 2002-08-09 Therapeutic use of aryl amino acid derivatives

Country Status (8)

Country Link
EP (1) EP1528919A2 (en)
JP (1) JP2006507238A (en)
AU (1) AU2003247056A1 (en)
BR (1) BR0313284A (en)
CA (1) CA2495108A1 (en)
GB (1) GB0218590D0 (en)
MX (1) MXPA05001534A (en)
WO (1) WO2004014357A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0759750A4 (en) * 1994-05-11 1998-05-27 Howard K Shapiro Compositions for treatment of chronic inflammatory diseases

Also Published As

Publication number Publication date
WO2004014357A3 (en) 2004-07-01
MXPA05001534A (en) 2005-04-19
CA2495108A1 (en) 2004-02-19
WO2004014357A2 (en) 2004-02-19
BR0313284A (en) 2005-07-12
EP1528919A2 (en) 2005-05-11
JP2006507238A (en) 2006-03-02
AU2003247056A1 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
IL165532A0 (en) Aryl carbonyl derivatives as therapeutic agents
HRP20041029A2 (en) Therapeutic use of selcetive pde10 inhibitors
IL164784A0 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
AU156078S (en) Set of cannula heads
EP1514106A4 (en) Targeted therapeutic proteins
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2003261251A1 (en) Methods of delivering therapeutic agents
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
NO20052894D0 (en) 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
IL165860A0 (en) Administration of therapeutic viruses
IL164266A0 (en) Treatment of gastroparesis
EP1551426A4 (en) Methods of administering fgf18
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
IL166337A0 (en) Oral administration of calctionin
GB0305150D0 (en) Use of therapeutic compounds
EP1487443A4 (en) Heterocyclic amide derivatives for the treatment of diabetes and other diseases
AU2003230566A8 (en) Therapeutic regulation of deoxyribonuclease-1-like-3 activity
GB0202900D0 (en) Novel formulations of drugs
ZA200500766B (en) Aryl carbonyl derivatives as therapeutic agents
AU2003219580A1 (en) Novel therapeutical use of byakangelicin
GB0210741D0 (en) Methods of therapy
GB0218590D0 (en) Therapeutic use of aryl amino acid derivatives
GB0315878D0 (en) Aryl carboxylic acid derivatives and their therapeutic use
AU2003253850A8 (en) Non-invasive measurement of ph

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)